Watson Pharma Private Limited

Watson Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U24230MH2005PTC156968 Incorporated 21 October 2005 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1,019.98 Cr
▼ 7.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹200 Cr
Registered with MCA
Paid-up capital
₹161.98 Cr
Issued & subscribed
Open charges
₹25 Cr
Satisfied ₹8.6 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
1,125
Latest available

About Watson Pharma Private Limited

Data last updated: 05 January 2026

Watson Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Watson Laboratories Inc. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 21 October 2005, the company has been in operation for over 21 years.

Registered with ROC Mumbai under CIN U24230MH2005PTC156968.

Capital: an authorised share capital of ₹200 Cr and a paid-up capital of ₹161.98 Cr. It is led by directors including Nishank Bhargava and Hemant Kumar Manilal Mamania.

Last AGM: 01 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹1,019.98 Cr, a decline of 7% compared to the previous year.

The company has a workforce of approximately 1,125 employees as per the latest available data. It operates as a subsidiary of Watson Laboratories Inc.

The company is associated with 1 brand - Pfizer. As per MCA filings, the company has open charges of ₹25 Cr and satisfied charges of ₹8.6 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tevapharm.in.

Company Details of Watson Pharma Private Limited
CIN U24230MH2005PTC156968
Registration Number 156968
Incorporation Date 21 October 2005
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 01 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Watson Laboratories Inc
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    8Th Floor Tower C Times Square Andheri Kurla Road Gamdevi Marol Andh, Eri East, Mumbai, Maharashtra, India – 400059
  • Industry
    Pharma, API Manufacturers, Pharma Contract R&D
Company report
Watson Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Watson Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Watson Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Watson Pharma Private Limited

Watson Pharma Private Limited operates one associated brand: Pfizer. These brands represent Watson Pharma Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Pharmaceutical products for treating multiple diseases are provided. pfizer.com

Competitors & Alternatives of Watson Pharma Private Limited

Brands and companies operating in the same space as Watson Pharma Private Limited include Merck, Roivant Sciences, AbbVie and 7 more.

Competitor Description Location Founded
Merck Merck Pharmaceutical products are manufactured and marketed worldwide. Kenilworth, United Kingdom, United Kingdom 1891
Roivant Sciences Roivant Sciences Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. New York, United States, United States 2014
AbbVie AbbVie Biopharmaceutical research and drug development are conducted globally by AbbVie. Chicago, United States, United States 2012
Lilly Lilly Traditional pharmaceutical medicines are developed for multiple health fields. United States 1876
Gilead Gilead Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others Foster City, United States, United States 1987
Pharmaron Pharmaron Drug discovery and development services for small molecules are provided. Beijing, China, China 2003
United Therapeutics United Therapeutics Treatments for chronic and life-threatening diseases are developed and commercialized. Silver Spring, United States, United States 1998
Roche Roche Pharmaceuticals and diagnostics kits are developed for various diseases. Basel, Switzerland, Switzerland 1896
MorphoSys MorphoSys Therapeutic antibodies for cancer and other diseases are developed. Planegg, Germany, Germany 1992
Vertex Pharmaceuticals Vertex Pharmaceuticals Developer of drugs for the treatment of multiple disorders United States 1989

Business Activity of Watson Pharma Private Limited

Watson Pharma Private Limited is engaged in principal business activities including manufacturing and professional, scientific and technical, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, other professional, scientific and technical activities. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
M Professional, Scientific and Technical M9 Other professional, scientific and technical activities Locked
Premium access

Business activity turnover details for Watson Pharma Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Watson Pharma Private Limited

Watson Pharma Private Limited is audited by S R B C & CO LLP for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
S R B C & CO LLP Locked Locked Locked
Premium access

Complete auditor history for Watson Pharma Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Watson Pharma Private Limited

Watson Pharma Private Limited is currently managed by 4 directors, with 26 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Nishank Bhargava Director 24 Feb 2022 4 Years 4 Months Current
Hemant Kumar Manilal Mamania Director 03 Jan 2022 4 Years 6 Months Current
Agnieszka Monika Lubkowska Director 26 Jun 2024 2 Years 0 Months Current
Chandrasekhar Bhagwan Sinha Director 08 Aug 2025 0 Years 11 Months Current

Financials of Watson Pharma Private Limited FY 2025 filings available

Watson Pharma Private Limited reported revenue of ₹1,019.98 Cr (down 7.00% YoY) for FY 2025.

Revenue · FY 2025
₹1,019.98 Cr ▼ 7.00%
Premium access

Ten-year financial statements for Watson Pharma Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Watson Pharma Private Limited

Premium access

Shareholding and ownership data for Watson Pharma Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Watson Pharma Private Limited

Open charges
₹25 Cr
Satisfied charges
₹8.6 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹25.00 Cr
Latest charge details
DateLenderAmountStatus
23 Jun 2009 Hdfc Bank Limited ₹25 Cr Open
29 Nov 2005 Standard Chartered Bank ₹80 Lakh Satisfied
23 Aug 2005 Standard Chartered Bank ₹80 Lakh Satisfied
30 Oct 2002 Bank of Baroda ₹3.5 Cr Satisfied
18 Jan 2002 Corporation Bank ₹3.5 Cr Satisfied

Total charge records: 5 View all charges

Employees and EPFO Compliance at Watson Pharma Private Limited

Watson Pharma Private Limited has a workforce of 1,125 employees as of Apr 08, 2024.

Employee count
1,125
Active EPFO establishments
1
Employee growth
-2.85%
Premium access

Employee and EPFO history for Watson Pharma Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Watson Pharma Private Limited

Premium access

GST registrations and filing compliance for Watson Pharma Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Watson Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Watson Pharma Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Watson Pharma Private Limited

Premium access

MSME payment history for Watson Pharma Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Watson Pharma Private Limited

Premium access

Corporate group structure for Watson Pharma Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Watson Pharma Private Limited

Premium access

MCA filings and documents for Watson Pharma Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Watson Pharma Private Limited

Activity
01 Sep 2025
Watson Pharma Private Limited last Annual general meeting of members was held on 01 Sep 2025 as per latest MCA records.
Directors
08 Aug 2025
Chandrasekhar Bhagwan Sinha was appointed as a Director on 08 Aug 2025 & has been associated with this company since 11 months 15 days.
Activity
31 Mar 2025
Watson Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
26 Jun 2024
Agnieszka Monika Lubkowska was appointed as a Director on 26 Jun 2024 & has been associated with this company since 2 years 27 days.
Directors
24 Feb 2022
Nishank Bhargava was appointed as a Director on 24 Feb 2022 & has been associated with this company since 4 years 4 months.
Directors
03 Jan 2022
Hemant Kumar Manilal Mamania was appointed as a Director on 03 Jan 2022 & has been associated with this company since 4 years 6 months.

Frequently Asked Questions about Watson Pharma Private Limited

Watson Pharma Private Limited is an active private limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 21 October 2005 (21+ years old) and is registered under CIN U24230MH2005PTC156968. The company has 1,125 employees.

Watson Pharma Private Limited reported revenue of ₹1,019.98 Cr for FY 2025 (down 7.00% YoY).

The current directors of Watson Pharma Private Limited are:

The primary industry of Watson Pharma Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Watson Pharma Private Limited can be reached at the registered office: 8Th Floor Tower C Times Square Andheri Kurla Road Gamdevi Marol Andh, Eri East, Mumbai, Maharashtra, India – 400059, or through the website tevapharm.in.

The authorised capital is ₹200 Cr, and the paid-up capital is ₹161.98 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available